CAS: 173867-04-4

Gambogellic acid is a naturally derived triterpenoid compound, which is sourced from certain Garcinia species, particularly prevalent in traditional Asian medicine. It exhibits a mode of action primarily through its ability to induce apoptosis and inhibit proliferation in cancer cells. This is largely attributed to its capability to modulate multiple signaling pathways involved in cell cycle regulation and apoptosis. Gambogellic acid's uses and applications in the scientific field are primarily centered around its potential as an anticancer agent. Studies have indicated promising results in pre-clinical models, showing its effectiveness in suppressing tumor growth and enhancing the efficacy of conventional chemotherapeutic agents. Furthermore, its anti-inflammatory properties may offer additional therapeutic avenues, warranting further investigation in inflammation-related pathologies. Given its multi-targeted approach, Gambogellic acid continues to be an attractive candidate for further research into drug development for various malignancies.

Gambogellic acid is an xanthone compound obtained from Garcinia cambogia and processed Gambog, is antitumor activity and cytotoxicity.